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In our study we present a case report of a 75-year-old patient with diabetes, chronic renal
insufficiency in a dialysis program following aorto-coronary bypass and repeated percu-
taneous interventional venous bypasses. We demonstrate the finding of a partial subacute
thrombosis of the stent in the venous bypass diagnosed using CT coronarography and its
therapy with thromboaspiration and IVUS guided rePCI. The discussion analyses occur-
rence, clinical manifestation and therapy of stent thrombosis based on the registry data
and a possibility of CT coronarography in the diagnosis of patency of the implanted stents.
& 2012 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
.1. Introduction
In-stent restenosis (ISR) is a serious problem after percutta-
neous coronary interventions (PCI) with implantation of a
bare metal stent. Risk factors of ISR include mainly diabetes
mellitus, complex lesions, venous graft, renal insufficiency,
acute coronary syndromes. The current treatment of choice
for in-stent restenosis is implantation of drug eluting stent
(DES), which effectively eliminates possible further in-stent
restenosis, however it is associated with a risk of late and
very late thrombosis [1,2].2. Case report
A 75-year-old patient was admitted to our department for
non-ST elevation acute myocardial infarction (NSTEMI). The
patient underwent repeated coronary events, aorto-coronary
bypass in 1995 (CABG; LIMA in LAD and venous bypasses inch Society of Cardiology.
leva).RCX and RCA) and subsequent coronary angioplastics in
venous bypasses. (PCI of the distal anastomosis LIMA in
LAD and venous bypasses in RCX and RCAwith implantation
of bare metal stents in 2005 and 2008).
Because of the advanced peripheral artery disease with signs
of critical ischemias, repeated pecruttaneous transluminal
angioplasty (PTA) of both femoral arteries was performed.
The patient underwent endarterectomy in 2000 due to
repeated cerebrovascular accidents and a 90% stenosis of
right arteria carotis interna.
Furthermore, the patient was treated due to non-insulin
dependent diabetes mellitus and was included in a regular
chronic dialysis program due to terminal renal insufficiency.
Repeated episodes of chest pain at rest with ST segment
depressions occurred during hospitalization. Maximum tropo-
nin I value was 1.5 ng/ml; only mildly reduced left ventricular
systolic function with an ejection fraction of 50% was found in
echocardiographic examination.
Selective coronarogaphy was performed with findings of
patent LIMA to LAD and venous graft to RCX and 75% in-stentPublished by Elsevier Urban & Partner Sp.z o.o. All rights reserved..
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coronary artery (RCA) (Fig. 1). This lession was treated with
implantation of drug eluting stent Promus 4.020mm (Fig. 2).
The patient was discharged after the procedure without limit-
ing chest pain with common dual anti-aggregation therapy
(ASA 100mg 11 and clopidogrel 75 mg 11).
The patient was hospitalized again 2 months later for
repeated NSTEMI, troponin I 4.5 ng/ml, which developed
during hemodialysis.
Difficult vascular access (PAD of the lower limbs after bilateral
PTA, extinct and functional AV shunt in both forearms) was
performed in the 1st stage angioCT (Fig. 3), which should be
sufficiently sensitive to evaluate patency of venous bypasses.
CT coronarography found patency of the intervened bypass but
a discrete, unclear lesion was found in the area of the implantedFig. 1 – In-stent
Fig. 2 – Drug eluting sdrug eluting stent (Figs. 4 and 5). The subsequent selective
coronarography through the right brachial artery demonstrated
‘‘hazy’’ lesion in the stent area (Fig. 6) and intravascular ultra-
sound (IVUS) examination confirmed partial subacute thrombo-
sis in the stent (Fig. 7).
The finding was solved by administration of 28mg of Reopro
and the thrombi were removed using the thromboaspiration
Export catheter (Fig. 8). Then a high-pressure postdilatation
using non-compliant balloon catheter (Quantun 4.515mm) at
14 atm was performed (Fig. 9) and the final IVUS check with a
satisfactory result (minimal stent area, MSA 12mm2). (Fig. 10)
Reopro infusion continued for 12 h after procedure with sub-
sequent prolonged dual antiaggregation therapy.
The patient had no limiting cardiac symptoms during the
follow-up.restenosis.
tent implantation.
Fig. 3 – CT coronarography VRT.
Fig. 4 – CT coronarography.
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According to the recommendation of the Academic Research
Consortium definite stent thrombosis is diagnosed when
either angiographic (and at least one clinical criteria) or
pathological confirmation is present. Probable stent throm-
bosis is clinically defined as any unexplained death within
the first 30 days after the index procedure or any MI in the
territory of the implanted stent without angiographic con-
firmation of ST and possible stent thrombosis as any unex-
plained death 30 days after intracoronary stenting.
According to the time of onset after the original PCI early
stent thombosis occurs within 30 days after stent implantationand it is further divided into acute (within 24 h) and subacute
(24 h to 30 days). Late stent thrombosis occurs between 1
month and 1 year after stent implantation and very late stent
thormbosis is any thrombosis in the stent after 1 year [4].
Most of the data on incidence, clinical manifestation,
therapy and follow-up of patients with ST come from regis-
tries [6–11]. The main risk factors of stent thrombosis were
diabetes mellitus, renal failure, acute coronary syndromes,
malignity, chronic closure, length of the lesion, affection of
LAD, suboptimal procedural result (post PCI TIMI flow grade
o3 ), uncovered dissection, stent undersizing, bifurcation
stenting, the presence of intermediate CAD proximal or distal
to the culprit lesion, left ventricular ejection fraction o30%,
early cessation of dual antiplatelet therapy. A relation between
Fig. 5 – CT coronarography.
Fig. 6 – Hazy lession.
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tion of clopidogrel in the previous 14 days was found, especially
in patients with DES. Residual dissection as a cause of STwas
significantly more common in patients with early ST vs. late/
very late ST. Stent thrombosis was clinically most often
manifested as acute coronary syndrome, mostly STEMI
(63–84%), less common as NSTEMI (13–34%), cardiogenic shock
(20%) or cardiac arrest and ventricular fibrillation (8%).
A complete closure of the intervened artery was found in
70–85% of cases. The treatment option included repeated
percutanenous intervention (94–97%), only POBA (29–64%),
thromboaspiration (30–51%) and in 36–61% cases implantation
of another stent was necessary. An optimal result, TIMI flow 3,
was achieved only in 64–88%. Use of GP IIb/IIIa blockers was
common (66%). The results of the therapy of stent thrombosiswere not satisfactory. 1-year mortality of patients with stent
thrombosis is 14–17% and recurrence of stent thrombosis was
found in 5–16% of cases. The type of the thrombotized stent
had no impact on clinical outcomes. The independent predic-
tors of long-term mortality were failure to achieve optimal
reperfusion and the need for implantation of another stent as
well as higher age and EF below 45% [6–11].
In our case the main risk factor, except for diabetes, was
terminal renal insufficiency that needed a chronic dialysis
program.
Renal insufficiency (RI) alone represents a strong predictor
of unfavorable outcomes after PCI. Chronic renal insuffi-
ciency in patients after PCI was associated with 2 higher
1-year mortality in mild RI, 5 higher in moderate RI and
12 higher in severe RI. RI results in complex impairment of
Fig. 7 – Thrombus detection by IVUS.
Fig. 8 – Thrombus apiration.
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platelet aggregation, dysfunction of the platelets) as well as
post-thrombotic conditions (increased levels of fibrinogen
and von Willebrand factor, which results in increased pro-
duction of thrombin and plasmin and reduction of anti-
thrombin III level) [12].
Because of the limited vascular access we used CT angio-
graphy as a primary diagnostic method to assess patency of
the implanted stent. Use of CT coronarography in the
demonstration of in-stent restenoses was assessed by Sun
in his meta-analysis. The achieved sensitivity and specificityof 64-slice CT angiography with the detection of in-stent
restenoses of 90% and 91%. Significantly higher diagnostic
success was achieved during the evaluation of stents with the
diameter greater than 3 mm (in comparison with stents
under 2.75 or 2.5 mm) [13]. The success achieved during the
evaluation of patency of venous bypass was still higher.
Weusting et al. in their report have shown up to 100%
sensitivity of 64-slice CT angiography in the detection of
obstructive impairment of venous grafts [14]. However the
evaluation of discreet lesions in coronary stents and in
venous grafts still remains difficult.
Fig. 9 – Final coronarography.
Fig. 10 – Final IVUS.
c o r e t v a s a 5 5 ( 2 0 1 3 ) e 2 6 4 – e 2 7 0 e269As with the therapy of acute myocardial infarction, aspira-
tion of the thrombus provides better results.
Mahmoud et al. in their report compared thromboaspira-
tion and common PCI in a group of 113 patients with stent
thrombosis. Post PCI TIMI flow 3 and MBG 2–3 were singifi-
cantly higher in thrombus aspiration group in comparison
with conventional PCI group (57% and 65% against 32% and
36%, p¼0.006 and 0.011). A trend towards better clinical
results of patients in the thrombus aspiration group was
observed as compared with the conventional PCI group,
although statistical significance has not been achieved.
1-year mortality in thrombus aspiration group compared
with the conventional PCI group was 12% against 21%(p¼0.22), recurrence of ST 9.8 against 11% (p¼0.758) and
MACE 34% against 41% (p¼0.391) [15].4. Conclusion
The incidence of ST within 1 year in BMS and DES stents is
similar, however DES stents demonstrate higher incidence of
very late ST after 1 year [3].
Stent thrombosis (ST) is manifested inmost cases as STEMI [3].
The treatment of choice is most frequently POBA (optimiza-
tion of the originally implanted stent), administration of GP
IIb/IIIa, thromboaspiration. It is suitable to avoid implantation
c o r e t v a s a 5 5 ( 2 0 1 3 ) e 2 6 4 – e 2 7 0e270of another stent. Achievement of optimal reperfusion (TIMI3,
MBG 2–3) is possible in significantly lower % of cases in
comparison with common PCI [5,6].
Long-term results (MACE, CV death, recurrence of ST) of ST
treatment are not optimal [7–11].
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